Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Agios Pharmaceuticals (AGIO) Receivables - Net (2016 - 2021)

Agios Pharmaceuticals' Receivables - Net history spans 8 years, with the latest figure at $4.4 million for Q4 2021.

  • For Q4 2021, Receivables - Net changed N/A year-over-year to $4.4 million; the TTM value through Dec 2021 reached $4.4 million, changed N/A, while the annual FY2021 figure was $4.4 million, 106.22% up from the prior year.
  • Receivables - Net reached $4.4 million in Q4 2021 per AGIO's latest filing, up from $2.3 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $19.3 million in Q2 2018 to a low of $779000.0 in Q2 2017.
  • Average Receivables - Net over 5 years is $3.7 million, with a median of $2.5 million recorded in 2019.
  • Peak YoY movement for Receivables - Net: skyrocketed 2380.87% in 2018, then crashed 86.94% in 2019.
  • A 5-year view of Receivables - Net shows it stood at $2.4 million in 2017, then rose by 0.57% to $2.5 million in 2018, then plummeted by 37.49% to $1.5 million in 2019, then skyrocketed by 51.66% to $2.3 million in 2020, then skyrocketed by 87.57% to $4.4 million in 2021.
  • Per Business Quant, the three most recent readings for AGIO's Receivables - Net are $4.4 million (Q4 2021), $2.3 million (Q3 2020), and $2.5 million (Q2 2020).